Arterial stiffness predicts risk for long-term recurrence in patients with type 2 diabetes admitted for acute coronary event

被引:14
|
作者
Levisianou, Dimitrios [1 ]
Foussas, Stefanos [2 ]
Skopelitis, Elias [1 ]
Adamopoulou, Evdokia [2 ]
Xenopoulou, Theodora [1 ]
Destounis, Antonios [2 ]
Koukoulis, Georgios [3 ]
Skoularigis, Ioannis [3 ]
Melidonis, Andreas [4 ]
Triposkiadis, Filippos [3 ]
机构
[1] Nikea Gen Hosp, Dept Internal Med 2, Nikea 18454, Greece
[2] Tzanio Gen Hosp, Dept Cardiol, Piraeus 18536, Greece
[3] Univ Thessaly, Univ Hosp Larissa, Sch Med, Dept Cardiol, Mezourlo 41110, Larissa, Greece
[4] Tzanio Gen Hosp, Diabet Outpatient Clin, Piraeus 18536, Greece
关键词
Arterial stiffness; Pulse wave velocity; Recurent acute coronary syndrome; PULSE-WAVE VELOCITY; AORTIC STIFFNESS; CARDIOVASCULAR MORTALITY; INDEPENDENT PREDICTOR; CARDIAC-HYPERTROPHY; HEART-DISEASE; TASK-FORCE; ALL-CAUSE; INHIBITION; STROKE;
D O I
10.1016/j.diabres.2012.11.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: to investigate the predictive value of arterial stiffness (AS) estimation for long-term recurrences in patients with type 2 diabetes (DM2) following acute coronary event. Patients and methods: prospective observational study involving 119 DM2 patients without history of coronary heart disease admitted with ST-segment elevation myocardial infarction (STEMI). Medical history, anthropometrics, smoking, HbA1c, lipid profile, troponine-I levels, and left ventricular ejection fraction (LVEF) were recorded. Carotid-femoral pulse wave velocity (cf-PWV) was measured 1 month after discharge. Patients were followed up for 36 months or to reach an end-point: cardiovascular death, acute coronary event, angioplasty or hospitalization for acute heart failure. To facilitate analysis, patients were divided into two groups according to cf-PWV, using the accepted cut-off value of 12 m/s. Results: overall, 34 patients had a recurrence. In Kaplan-Meier analysis patients with cf-PWV > 12 m/s had mean time-to-event 353 +/- 43 days compared to 505 +/- 115 days for patients with cf-PWV <= 12 m/s, log rank = 0.0252. In multivariate analysis factors independently associated with recurrence were age (66.53 +/- 6.87 vs. 61.54 +/- 10.77 years, p = 0.015), LVEF (41.66 +/- 8.21 vs. 47.58 +/- 8.11%, p = 0.001) and cf-PWV (13.94 +/- 2.91 vs. 12.35 +/- 2.77 m/s, p = 0.008). Conclusions: AS estimation in patients with DM2 after STEMI discriminate patients at higher risk for 3-year recurrence, and maybe valuable for distinguishing patients likely to require a more rigorous therapeutic intervention. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:315 / 320
页数:6
相关论文
共 50 条
  • [11] Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes
    D. Gordin
    M. Rönnback
    C. Forsblom
    O. Heikkilä
    M. Saraheimo
    P.-H. Groop
    Diabetologia, 2007, 50 : 1808 - 1814
  • [12] Increased high-risk coronary plaque burden is associated with arterial stiffness in patients with type 2 diabetes without clinical signs of coronary artery disease: a computed tomography angiography study
    Funck, Kristian L.
    Laugesen, Esben
    Ovrehus, Kristian
    Jensen, Jesper M.
    Norgaard, Bjarne L.
    Dey, Damini
    Hansen, Troels K.
    Poulsen, Per L.
    JOURNAL OF HYPERTENSION, 2017, 35 (06) : 1235 - 1243
  • [13] Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction
    Bruno, R. M.
    Penno, G.
    Daniele, G.
    Pucci, L.
    Lucchesi, D.
    Stea, F.
    Landini, L.
    Cartoni, G.
    Taddei, S.
    Ghiadoni, L.
    Del Prato, S.
    DIABETOLOGIA, 2012, 55 (06) : 1847 - 1855
  • [14] The association between arterial stiffness and tongue manifestations of blood stasis in patients with type 2 diabetes
    Hsu, Po-Chi
    Huang, Yu-Chuen
    Chiang, John Y.
    Chang, Hen-Hong
    Liao, Pei-Yung
    Lo, Lun-Chien
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 16
  • [15] Study of arterial stiffness in patients with an acute coronary event and chronic obstructive pulmonary disease confirmed by spirometry
    Almagro, P.
    Acosta, E.
    Navarro, A.
    Murillo, M. F.
    Valdivielso, S.
    de la Sierra, A.
    REVISTA CLINICA ESPANOLA, 2019, 219 (05): : 251 - 255
  • [16] Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study
    Sakura, Takeshi
    Morioka, Tomoaki
    Shioi, Atsushi
    Kakutani, Yoshinori
    Miki, Yuya
    Yamazaki, Yuko
    Motoyama, Koka
    Mori, Katsuhito
    Fukumoto, Shinya
    Shoji, Tetsuo
    Emoto, Masanori
    Inaba, Masaaki
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [17] Acute and Long-Term Consequences of COVID-19 on Arterial Stiffness-A Narrative Review
    Zota, Ioana Madalina
    Statescu, Cristian
    Sascau, Radu Andy
    Roca, Mihai
    Anghel, Larisa
    Mastaleru, Alexandra
    Leon-Constantin, Maria Magdalena
    Ghiciuc, Cristina Mihaela
    Cozma, Sebastian Romica
    Dima-Cozma, Lucia Corina
    Esanu, Irina Mihaela
    Mitu, Florin
    LIFE-BASEL, 2022, 12 (06):
  • [18] Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus
    Ioanna Zografou
    Christos Sampanis
    Eugenia Gkaliagkousi
    Fotios Iliadis
    Athanasios Papageorgiou
    Panagiotis Doukelis
    Konstantinos Vogiatzis
    Stella Douma
    Hormones, 2015, 14 (1) : 118 - 125
  • [19] Long-Term Risk of Stroke in Patients With Type 1 and Type 2 Diabetes Following Coronary Artery Bypass Grafting
    Nystrom, Thomas
    Holzmann, Martin J.
    Sartipy, Ulrik
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2015, 4 (11):
  • [20] Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus
    Zografou, Ioanna
    Sampanis, Christos
    Gkaliagkousi, Eugenia
    Iliadis, Fotios
    Papageorgiou, Athanasios
    Doukelis, Panagiotis
    Vogiatzis, Konstantinos
    Dolma, Stella
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 14 (01): : 118 - 125